Study of Oral Fampridine-SR in Multiple Sclerosis
Clinical trial NCT00127530 · COMPLETED
Trial details
- NCT number
- NCT00127530
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2006-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.